NCT06559566

Brief Summary

Ultrasonography(USG)-guided optic nerve sheath diameter measurement and its correlation with brain computed tomography in the evaluation of intracranial pressure in patients who underwent intracranial brain tumor surgery.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2024

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 31, 2024

Completed
19 days until next milestone

First Posted

Study publicly available on registry

August 19, 2024

Completed
27 days until next milestone

Study Start

First participant enrolled

September 15, 2024

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2025

Completed
Last Updated

August 19, 2024

Status Verified

August 1, 2024

Enrollment Period

5 months

First QC Date

July 31, 2024

Last Update Submit

August 15, 2024

Conditions

Keywords

OPTIC NERVEINTRACRANIAL PRESSUREINTRACRANIAL TUMORINTRACRANIAL TUMOR SURGERYIntracranial Pressure Change

Outcome Measures

Primary Outcomes (1)

  • intracranial pressure

    To compare the optic nerve diameter measurement ,USG and BBT values used to measure intracranial pressure in patients with brain tumor surgery

    T0: Before anesthesia induction T1: peroperative5. minutes T2: At the end of the surgery 6.hours T3:after extubation 1 hours T4: postoperative 12.hours T5. postoperative 24.hours

Secondary Outcomes (2)

  • Heart Rate

    T0: Before anesthesia induction T1: preoperative 5.minutes T2: At the end of the surgery 6.hoursT3:after extubation 1 hours T4: postoperative 12.hours T5. postoperative 24.hours

  • Blood pressure

    T0: Before anesthesia induction T1: preoperative 5.minutes T2: At the end of the surgery 6.hours T3 extubation 1 hours T4: postoperative 12.hours T5. postoperative 24.hours

Study Arms (2)

ONSD measurement with USG

ACTIVE COMPARATOR

After the ONSD measurement is made before anesthesia induction, general anesthesia will be given to each patient according to the institutional protocol. The ONSD measurements of the patients will be measured according to the T0, T1, T2, T3, T4, T5 time period by a person who has experience in using USG T0: Before anesthesia induction T1: First 5 minutes immediately after induction of anesthesia T2: At the end of the surgery before extubation /minute T3: Within the first hour/minute after extubation T4: 12 hours/minute after tumor resection T5. 24 hours/minute after tumor resection

Procedure: USG

ONSD measurement with BCT

ACTIVE COMPARATOR

In patients, USG and BCT correlation comparison is planned before the operation (T0), in the first hour after the end of post-operative surgery (T3) and at the 24th hour after post-operative surgery (T5). T0: ONSD measurement in pre-operative BCT T3: BCT ONSD measurement/minute within the first hour following the postoperative period T5: BCT ONSD measurement/minute 24 hours following the postoperative period The measurement of ONSD in BCT is; Eyeball diameter and optic nerve diameter measurements will be made on BCT transverse images at the optic nerve level and recorded.

Procedure: BCT

Interventions

USGPROCEDURE

The aim of this study is to measure the intracranial pressure of patients planned for brain tumor surgery by measuring the optic nerve sheath diameter (ONSD) under USG guidance and compare its correlation with the computed brain tomography.

Also known as: ONSD measurement with USG
ONSD measurement with USG
BCTPROCEDURE

The aim of this study is to measure the intracranial pressure of patients planned for brain tumor surgery by measuring the optic nerve sheath diameter (ONSD) under USG guidance and compare its correlation with the computed brain tomography.

Also known as: ONSD measurement with BCT
ONSD measurement with BCT

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients over 18 -65 years
  • Brain malignant neoplasm tumor
  • Brain benign neoplasm supratentorial
  • Brain benign neoplasm infratentorial information

You may not qualify if:

  • Patients who cannot provide adequate image quality in ocular ultrasonography
  • Who are unconscious or have a Glasgow coma scale of less than 15
  • Pseudotumor cerebri
  • Optic nerve arachnoid cyst
  • Patients with open injuries involving the eyelid and surrounding area
  • Optic nerve malignant neoplasm
  • Injury of the optic nerve and its pathways
  • Systemic Lupus Erythematosis,
  • Scleroderma
  • Multiple Sclerosis, sarcoidosis
  • Thyrotoxicosis (hyperthyroidism)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (3)

  • Stevens RRF, Gommer ED, Aries MJH, Ertl M, Mess WH, Huberts W, Delhaas T. Optic nerve sheath diameter assessment by neurosonology: A review of methodologic discrepancies. J Neuroimaging. 2021 Sep;31(5):814-825. doi: 10.1111/jon.12906. Epub 2021 Jul 16.

    PMID: 34270144BACKGROUND
  • Raffiz M, Abdullah JM. Optic nerve sheath diameter measurement: a means of detecting raised ICP in adult traumatic and non-traumatic neurosurgical patients. Am J Emerg Med. 2017 Jan;35(1):150-153. doi: 10.1016/j.ajem.2016.09.044. Epub 2016 Sep 23.

    PMID: 27852525BACKGROUND
  • Xu J, Song Y, Shah Nayaz BM, Shi W, Zhao Y, Liu Y, Wu S, Li Z, Sun Y, Zhao Y, Yu W, Wang X. Optic Nerve Sheath Diameter Sonography for the Diagnosis of Intracranial Hypertension in Traumatic Brain Injury: A Systematic Review and Meta-Analysis. World Neurosurg. 2024 Feb;182:136-143. doi: 10.1016/j.wneu.2023.11.016. Epub 2023 Nov 10.

    PMID: 37951461BACKGROUND

MeSH Terms

Conditions

Brain Neoplasms

Condition Hierarchy (Ancestors)

Central Nervous System NeoplasmsNervous System NeoplasmsNeoplasms by SiteNeoplasmsBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • SEZEN KUMAS SOLAK, MD

    Bagcılar Training Research Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

SEZEN KUMAS SOLAK, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR INVESTIGATOR
PI Title
SPONSOR INVESTIGATOR

Study Record Dates

First Submitted

July 31, 2024

First Posted

August 19, 2024

Study Start

September 15, 2024

Primary Completion

February 1, 2025

Study Completion

May 1, 2025

Last Updated

August 19, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

The investigators will not share individual patient data